OVA mRNA
Ready-to-use stabilized OVA mRNA
Concentration: 1.0 mg/mL in 1 mM Sodium Citrate, pH 6.4.
mRNA length: 1375 nt. MW MRNA42= 445528 g/mol; MRNA41= 451168 g/mol ; MRNA40= 448348 g/mol
OVA mRNAs have been designed to produce high expression level of Ovalbumin protein.
OZB mRNAs are produced by in vitro transcription. mRNAs are stabilized at the 5’ end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 3’ end. Sequences have been optimized to yield improved stability and performance.
OVA mRNAs:
- #MRNA42 does not bear any additional nucleotide modifications.
- #MRNA41 is modified with 5-methoxyuridine (5moU) to reduce innate immune responses.
- #MRNA40 is modified with N1-methyl-pseudouridine (N1-mψ) to reduce innate immune response.
Standard QC | Superior Grade QC* | |
Fragment analyzer | ✔ | ✔ |
Agarose gel | ✔ | ✔ |
Concentration (260/280 & 260/230) | ✔ | ✔ |
Sterility test | ✔ | ✔ |
Transfection/Expression | ✔ | ✔ |
Endotoxin | ✔ | |
dsRNA | ✔ |
* Contact us to get a quote.
We recommend using our transfection reagents RmesFect or RmesFect Stem in order to reach high transfection efficiency and optimum protein expression level.
Size: 20 µg, 100µg or 1 mg.
For bulk, please contact us: order@ozbiosciences.com
Storage: -80°C
mRNAs ARE SHIPPED WITH DRY ICE
Dry ice fee included in shipping cost
Please log in or register to see the prices for your country
Catalog number | Unit Size | Price excl tax | Quantity / Buy |
MRNA41-20 |
OVA mRNA (5moU) 20µg
|
$184.00
|
|
MRNA41-100 |
OVA mRNA (5moU) 100µg
|
$350.00
|
|
MRNA41-1000 |
OVA mRNA (5moU) 1mg
|
$1,878.00
|
|
MRNA42-20 |
Unmodified OVA mRNA 20µg
|
$176.00
|
|
MRNA42-100 |
Unmodified OVA mRNA 100µg
|
$282.00
|
|
MRNA42-1000 |
Unmodified OVA mRNA 1 mg
|
$1,556.00
|
|
MRNA40-20 |
OVA mRNA (N1-mψ) 20µg
|
$206.00
|
|
MRNA40-100 |
OVA mRNA (N1-mψ) 100µg
|
$372.00
|
|
MRNA40-1000 |
OVA mRNA (N1-mψ) 1 mg
|
$1,901.00
|
|
Citation database
NAME | MOLECULE VECTOR | PRODUCT | REFERENCE | |
all cells | 0 | OVA mRNA | Tai JA Vaccines (Basel). 2024 Jul 9;12(7):757. | |
all cells | 0 | OVA mRNA | Binici B. Vaccines (Basel). 2024 Mar 7;12(3):282. | |
all cells | 0 | OVA mRNA | Jeger-Madiot R. bioRxiv 2024 https://doi.org/10.1101/2024.02.02.578553 |
Related products